A Spot of Trouble with Varonis

by

It appears Greenvale Capital, a firm of generally sound judgement (or so one assumes), has rather briskly disposed of its entire holding in Varonis Systems. Ninety-nine million dollars’ worth, if you please! A tidy sum, naturally, and one can’t help but wonder what prompted such a decisive exit. The market, as ever, is a beast of habit and a touch unpredictable, and one suspects a spot of bother has manifested itself.

A Most Curious Situation

According to a filing with the authorities – a frightfully official document, no doubt – Greenvale has relieved itself of some 1,725,000 shares in Varonis. The value, alas, has dwindled to precisely nothing, a diminution of ninety-nine million dollars from the previous period. A rather dramatic turn of events, wouldn’t you agree? It rather suggests the firm had a sneaking suspicion that things weren’t quite cricket.

Further Particulars

It seems Greenvale’s Varonis stake, once a rather substantial 7.8% of their assets under management, has been entirely liquidated. A clean sweep, as it were. One gathers they’ve been reallocating funds to more promising ventures. A sensible precaution, one feels. Their current affections lie with the likes of RUN, ZETA, SN, OKTA, and ENPH – a rather diverse portfolio, and all showing considerably more pep, if the latest reports are to be believed.

  • NASDAQ:RUN: $197.23 million (18.5% of AUM)
  • NYSE:ZETA: $142.91 million (13.4% of AUM)
  • NYSE:SN: $116.57 million (10.9% of AUM)
  • NASDAQ:OKTA: $81.71 million (7.7% of AUM)
  • NASDAQ:ENPH: $75.32 million (7.1% of AUM)

As of February the thirteenth, Varonis shares were fetching a mere $25.36 – a considerable tumble of 40% over the past year. The S&P 500, meanwhile, has been cheerfully bounding along, gaining some 20% in the same period. A rather stark contrast, wouldn’t you say? One begins to suspect Varonis has been a bit of a drag on the portfolio.

A Brief Overview of the Firm

Varonis, for the uninitiated, purveys software solutions for data security, analytics, and access management. They offer a veritable cornucopia of products – DatAdvantage, DatAlert, and the like – designed to keep one’s digital assets safe and sound. They cater to enterprises across the globe, assisting them in managing sensitive data and complying with regulations. A useful service, certainly, but one that appears to be facing a spot of difficulty at present.

Metric Value
Revenue (TTM) $623.53 million
Net Income (TTM) ($129.32 million)
Price (as of market close 2/13/26) $25.36
One-Year Price Change -41.99%

The Meaning of This for the Discerning Investor

Sharp declines in stock prices, as Varonis has experienced, can be rather unsettling. It appears management, in a moment of frankness, revealed that their transition to a subscription and SaaS model was taking longer than anticipated. This pronouncement, alas, triggered a rather precipitous plunge in October, wiping out two years of gains almost overnight. Shares, even months later, remain down some 40% year-on-year. A dashedly unpleasant state of affairs, to be sure.

The cybersecurity sector, whilst generally rewarding patience, can be a fickle mistress. The market’s reaction to Varonis demonstrates how quickly sentiment can turn when growth expectations are dashed. The firm recently reported a 16% increase in annual recurring revenues and a rise in full-year revenue to $623.5 million, but it may not be sufficient for investors craving explosive growth. One suspects the market demands a rather more vigorous performance.

Against this backdrop, Greenvale’s repositioning appears perfectly logical. They’ve chosen to allocate funds to firms exhibiting more robust growth prospects, such as Zeta Global, Okta, and Sunrun. A sensible precaution, and one that suggests a certain degree of shrewdness. One might even venture to say they’ve avoided a bit of a pickle. After all, in the grand scheme of things, a bit of portfolio pruning is always a good idea, wouldn’t you agree?

Read More

2026-03-12 21:47